Sphingosine-1-phosphate (S1P) receptor modulators
- Name
- Sphingosine-1-phosphate (S1P) receptor modulators
- Accession Number
- DBCAT005916
- Description
Not Available
- ATC Classification
- Drugs
Drug Drug Description Fingolimod A sphingosine 1-phosphate receptor modulator used to treat patients with the relapsing-remitting form of multiple sclerosis (MS) and studied to manage lung complications of COVID-19. Ponesimod A sphingosine 1-phosphate receptor modulator indicated to treat relapsing multiple sclerosis. Siponimod A medication used to treat relapsing multiple sclerosis. Ozanimod A sphingosine 1-phosphate receptor modulator being studied to treat Multiple Sclerosis (MS) and inflammatory bowel disease (IBD). Etrasimod An S1P receptors modulator used to treat moderate to severely active ulcerative colitis in adults - Drugs & Drug Targets